CN105496992A — 氨溴索沙丁胺醇脂质固体分散体
Assigned to Qingdao Chia Tai Haier Pharmaceutical Co Ltd · Expires 2016-04-20 · 10y expired
What this patent protects
本发明涉及氨溴索沙丁胺醇脂质固体分散体及其制备方法,属于药物制剂领域。本发明的脂质固体分散体包含盐酸氨溴索、硫酸沙丁胺醇和丁基羟基茴香醚,脂质载体为25%三月桂酸甘油酯、30%椰子油、15%聚乙二醇辛酸/癸酸甘油酯、20%维生素E醋酸酯和10%PEG200组成的混合物,固体载体为30%微粉硅胶和70%玉米淀粉的混合物,质量稳定,效果显著,可有效治疗急慢性支气管炎和哮喘等呼吸系统疾病。
USPTO Abstract
本发明涉及氨溴索沙丁胺醇脂质固体分散体及其制备方法,属于药物制剂领域。本发明的脂质固体分散体包含盐酸氨溴索、硫酸沙丁胺醇和丁基羟基茴香醚,脂质载体为25%三月桂酸甘油酯、30%椰子油、15%聚乙二醇辛酸/癸酸甘油酯、20%维生素E醋酸酯和10%PEG200组成的混合物,固体载体为30%微粉硅胶和70%玉米淀粉的混合物,质量稳定,效果显著,可有效治疗急慢性支气管炎和哮喘等呼吸系统疾病。
Drugs covered by this patent
- Camptosar (Irinotecan Hydrochloride) · Pfizer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.